百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONC 百济神州

已收盘 05-19 16:00:00 EDT

297.01

+3.92

+1.34%

盘后297.01

+0.000.00%

17:57 EDT

最高297.36	最低290.05	成交量21.91万
今开292.02	昨收293.09	日振幅2.50%
总市值329.68亿	流通市值253.79亿	总股本1.11亿
成交额6,458万	换手率0.26%	流通股本8,545万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":297.01,"timestamp":1779220800000,"preClose":293.09,"halted":0,"volume":219131,"hourTrading":{"tag":"盘后","latestPrice":297.01,"preClose":297.01,"latestTime":"17:57 EDT","volume":2600,"amount":772280.96,"timestamp":1779227850913,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.013374731311201394,"floatShares":85449100,"shares":111000000,"eps":4.404108,"marketStatus":"已收盘","change":3.92,"latestTime":"05-19 16:00:00 EDT","open":292.02,"high":297.36,"low":290.045,"amount":64584234.20328,"amplitude":0.024958,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.404108,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779264000000},"marketStatusCode":5,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":293.09,"preHourTrading":{"tag":"盘前","latestPrice":300,"preClose":293.09,"latestTime":"06:51 EDT","volume":514,"amount":148929.54679999998,"timestamp":1779187919935,"change":6.91,"changeRate":0.023576,"amplitude":0.034119},"postHourTrading":{"tag":"盘后","latestPrice":297.01,"preClose":297.01,"latestTime":"17:57 EDT","volume":2600,"amount":772280.96,"timestamp":1779227850913,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.91351,"impliedVol":0.3482,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/ONC","defaultTab":"news","newsList":[{"id":"2636885146","title":"生物医药板块盘初普涨 药明合联(02268)涨5.24%、百济神州(06160)涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885146","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636885146?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:46","pubTimestamp":1779155169,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股生物医药板块盘初普涨，截至发稿，药明合联 涨5.24%，科伦博泰生物涨4.01%，百济神州涨2.17%，诺诚健华涨2.00%，药明生物涨1.58%，康诺亚-B涨1.35%，金斯瑞生物科技涨1.12%。消息面上，中邮证券研究表示，26年有望迎来BD和重点项目数据读出的双重催化，国产创新药全球性竞争力提升逻辑不断强化。建议关注确定性高、BD预期扰动相对小的标的。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","HK0000320264.USD","399441","LU0307460666.USD","02268","SG9999014674.SGD","LU0417516902.SGD","LU1719994722.HKD","LU0052750758.USD","XBI","BK1574","01548","BK4588","LU1242518931.SGD","06990","BK1588","LU1688375341.USD","LU0456846285.SGD","LU0359201612.USD","LU0359202008.SGD","LU1770034418.SGD","LU0823426308.USD","LU0043850808.USD","09969","161726","BK1589","LU0516422366.SGD","LU1251922891.USD","06160","LU1303224171.USD","BK1161","BK1583","688235","LU0417516738.SGD","LU0320764599.SGD","02269","LU0181495838.USD","ONC","IE00B0JY6N72.USD","HK0000306701.USD","BK1576","SG9999002562.SGD","LU0708995583.HKD","LU0039217434.USD","LU0516422440.USD","BK1141","LU0348825331.USD","LU3063872942.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636883343","title":"大行集体看涨百济神州(06160)，\tQ1业绩印证长期投资价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2636883343","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636883343?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:10","pubTimestamp":1779153033,"startTime":"0","endTime":"0","summary":"GAAP口径下，百济神州Q1季度全球总收入达15.13亿美元，同比增长35.5%，超出此前FactSet一致预期的14.4亿美元。26Q1季度，百济神州产品收入达15亿美元，同比增长34%。该行在将百济神州维持“买入”评级的同时，将其美股目标价由430美元进一步上调至453美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ONC","LU1969619763.USD","BK1161","LU1770034418.SGD","LU1251922891.USD","BK4585","06160","LU1303224171.USD","BK1500","BK4139","BK1583","BK0239","LU0588546209.SGD","LU2328871848.SGD","688235","BK4588","BK4526","BK1588","LU0307460666.USD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636023442","title":"百济神州正在接近生命周期的一次切换","url":"https://stock-news.laohu8.com/highlight/detail?id=2636023442","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636023442?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:13","pubTimestamp":1779092018,"startTime":"0","endTime":"0","summary":"文｜锦缎市场整体下跌时，百济神州再次成为资金流出的对象。BTK叙事的延伸一个常见的解读是，百济神州又增加了一款新药。从单品到矩阵的跃迁，本质上是公司生命周期的一次切换。索托克拉的获批，是百济神州在这条路径上迈出的一步。泽布替尼代表了百济神州的过去和现在。百济神州拿到了一张关键牌，但牌局远未到收官的阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1779076618818843533","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4588","BK1500","LU2328871848.SGD","688235","LU1969619763.USD","06160","BK4585","LU1719994722.HKD","BK1583","LU1770034418.SGD","LU0588546209.SGD","BK4139","BK0239","LU1251922891.USD","LU1303224171.USD","ONC","BK4526","LU0307460666.USD","BK1588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636702309","title":"美股中概股盘前涨跌互现，百度、阿里巴巴涨1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636702309","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636702309?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:02","pubTimestamp":1779091355,"startTime":"0","endTime":"0","summary":"5月18日，美股中概股盘前涨跌互现，百度、阿里巴巴涨1%，京东涨0.4%，拼多多持平，网易跌0.3%，百济神州跌0.8%，携程跌1%，理想汽车跌10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605183740446853.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605183740446853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XPP","82822","09888","BK4579","BK4558","LU1003077747.HKD","LU0359201612.USD","02015","LU1152091754.HKD","LU1048596156.SGD","BK4504","BK4612","LU1688375341.USD","BK4505","LU1267930227.SGD","BK4554","LU0173614495.USD","HXC","LU1105468828.SGD","BK4548","LU1046421795.USD","KBAB","BABA","BK4527","LU0651947912.USD","LU2226246903.HKD","BABO","LU0072913022.USD","LU0553294199.USD","LU0052756011.USD","BK4574","ASHR","BK4587","BK4585","MCHI","BK4535","LU1235294995.USD","82823","BBYY","BK4607","LU1048588211.SGD","BK4550","BK4514","LU0918141705.HKD","LU0359202008.SGD","LU1242518931.SGD","BK4526","LU0545039389.USD","LU0067412154.USD","PDD","LU1282648689.USD","IE00BFMHRM44.USD","LI","JD","BK4614","LU1515016050.SGD","BK4552","LU0651946864.USD","TCOM","BK4502","LU1046422090.SGD","LU0949170772.SGD","BK4122","LU0880133367.SGD","ONC","LU0661504455.SGD","09999","LU1051769294.HKD","LU0918141887.USD","02843","BK4588","LU0287142896.SGD","BK4220","YXI","LU1823568750.SGD","BK4565","02823","BK4602","LU0348814723.USD","LU1769817096.USD","02822","LU0348816934.USD","LU2148611432.USD","LU0797268264.HKD","LU0251143458.SGD","DRAG","LU0106959298.USD","06160","LU1880383366.USD","09988","BK4533","LU1242518857.USD","LU1115378108.SGD","BIDU","LU1769817179.HKD","BABW","BK4077","KBDU","ALBmain","82843","LU0310800965.SGD","BK4543","LU0328353924.USD","BK4503","LU0072462343.USD","LU1152091168.USD","ASHS","BABU","BK4581","LU0640798160.USD","BK4534","LU1008478684.HKD","LU0047713382.USD","LU0738911758.USD","BK4575","FLCH","LU0456842615.SGD","LU0821914370.USD","BIDG","LU1023057109.AUD","BK4531","LU0963586101.USD","IE00B0JY6N72.USD","BK4524","FXP","09618","688235","LU0501845795.SGD","09961","BABX","LU0128525689.USD","BK4538","CWEB","LU0979878070.USD","LU1051768304.USD","NTES","IE00BF5LJ272.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635936752","title":"百济神州(06160)：百悦达®获美国FDA批准成为美国首款且目前唯一治疗复发╱难治套细胞淋巴瘤的BCL2抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2635936752","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635936752?lang=zh_cn&edition=full","pubTime":"2026-05-14 07:47","pubTimestamp":1778716032,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，公司于2026年5月13日宣布百悦达获得美国食品药品监督管理局加速批准，用于治疗既往接受过至少两线系统治疗的复发或难治性(R/R)套细胞淋巴瘤成人患者。索托克拉是一款在BCL2靶点研发中具有基石性潜力的新一代BCL2抑制剂，其研发设计以增强BCL2抑制剂作用为目标，在分子效力和选择性方面进行了优化，且其药理学特性也有望改善用药的有效性、耐受性和便利性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1588","LU1719994722.HKD","LU2328871848.SGD","LU1770034418.SGD","LU1303224171.USD","BK0239","BK1500","BK4588","LU0307460666.USD","LABU","LU1969619763.USD","06160","LU1251922891.USD","BK4139","BK1161","ONC","BK4585","LU0588546209.SGD","BK4526","688235"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2635202523","title":"百济神州(06160)：授出受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2635202523","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635202523?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:04","pubTimestamp":1778663056,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年5月8日，董事会薪酬委员会根据2016期权及激励计划的条款向201名承授人授出涉及合共25,436股美国存托股份的受限制股份单位。该等受限制股份单位相当于330,668股股份，约占本公告之日公司发行股份总数的0.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0307460666.USD","BK1161","BK4588","BK4526","LU1303224171.USD","06160","LU2328871848.SGD","LU1719994722.HKD","BK4139","BK4585","LU0588546209.SGD","BK1500","BK1583","688235","BK0239","LU1969619763.USD","LU1770034418.SGD","BK1588","LU1251922891.USD","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634228933","title":"百济神州一季度净利润超16亿元；今年医保谈判工作启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634228933","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634228933?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:04","pubTimestamp":1778501046,"startTime":"0","endTime":"0","summary":"政策动向今年医保谈判工作启动近日，国家医保局发布《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》，并向社会公开征求意见。21点评：根据《征求意见稿》，今年的工作程序仍分为准备、申报、评审、谈判、公布结果5个阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113733316580.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113733316580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688235","06160","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634288993","title":"百济神州(06160)发布第一季度业绩 归母净利润16.08亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2634288993","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634288993?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:57","pubTimestamp":1778497043,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布2026年第一季度业绩，该集团取得营业收入105.44亿元，同比增长31.0%;归属于上市公司股东的净利润16.08亿元，同比扭亏为盈;基本每股收益1.11元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688235","06160","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633486147","title":"【券商聚焦】招银国际维持百济神州(ONC/06160)“买入”评级 指近期临床数据读出将验证创新管线价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2633486147","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633486147?lang=zh_cn&edition=full","pubTime":"2026-05-08 13:17","pubTimestamp":1778217451,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指，百济神州 1Q26业绩强劲，盈利改善，管理层上调全年指引。此外，近期多项临床数据的读出将为公司估值的提升提供强有力的催化剂。此外，BTK CDAC的美国NDA预计将于下半年递交。实体瘤催化剂丰富： 在即将到来的ASCO年会上，公司将公布CDK4抑制剂、GPC3/4-1BB双抗及B7-H4 ADC的临床数据。CDK4抑制剂已经进入一线乳腺癌三期临床。GPC3/4-1BB双抗也已经进入后线肝癌注册临床阶段。维持“买入”评级，维持基于DCF模型的目标价392.43美元不变。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980931","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","06160","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633107844","title":"中金：维持百济神州(06160)跑赢行业评级 目标价250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633107844","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633107844?lang=zh_cn&edition=full","pubTime":"2026-05-08 09:37","pubTimestamp":1778204248,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，综合考虑百济神州费用控制，维持2026年收入预测不变，上调盈利预测7.1%至6.5亿美元，并维持2027年盈利预测不变。该行维持跑赢行业评级，基于DCF模型，该行维持A/H/US股目标价320元/250港币/420美元。1Q26替雷利珠单抗全球销售额2.06亿美元，YoY +20%。GAAP净利润达到2.27亿美元，单季度盈利首次超过2亿美元，超过该行预期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ONC","688235","06160","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633794147","title":"多家药企高管生变：恒瑞、复星、阿斯利康、辉瑞…","url":"https://stock-news.laohu8.com/highlight/detail?id=2633794147","media":"赛柏蓝","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633794147?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:53","pubTimestamp":1778154780,"startTime":"0","endTime":"0","summary":"01本土制药企业与Biotech迎高管变动恒瑞医药、再鼎医药、百济神州、和铂医药、复星医药映射出了中国创新药发展过程中企业所处的不同阶段。4月16日，恒瑞医药发布公告，正式完成新一届董事会和管理层聘任。复星医药4月2日，复星医药发布首席财务官变更公告，因工作安排调整，陈战宇辞去首席财务官职务。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-07/doc-inhxatff4708181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0889565916.HKD","AZNH","LU0321505439.SGD","LU2237443895.HKD","BK4599","SG9999002232.USD","BK4581","BK4550","IE00BLSP4452.SGD","BK4533","LU0122379950.USD","BK4592","SG9999011175.SGD","LU0456855351.SGD","LU1066051498.USD","LU0320765992.SGD","LU2417539215.USD","LU0289739699.SGD","LU2237443622.USD","600196","LU1066053197.SGD","02142","IE00B3T34201.USD","LU0234572021.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0225284248.USD","01276","LU0321505868.SGD","LU2462157665.USD","BK4588","LU2236285917.USD","LU2456880835.USD","BK4585","IE00B19Z3B42.SGD","LU0109394709.USD","688235","IE00BLSP4239.USD","LU1023059063.AUD","LU1057294990.SGD","IE00BBT3K403.USD","LU2237443382.USD","02196","LU0170899867.USD","LU0058720904.USD","LU0868494617.USD","SG9999003800.SGD","SG9999013999.USD","SGXZ57979304.SGD","06160","LU2237443549.SGD","LU1883839398.USD","LU1894683348.USD","LU0985481810.HKD","LU2237443978.SGD","SG9999001176.USD","SG9999001176.SGD","BK4534","600276","LU0225771236.USD","LU0306807586.USD","LU2237443465.HKD","AZN","PFE","SG9999002224.SGD","LU0306806265.USD","IE000M9KFDE8.USD","LU1894683264.USD","BK4568","ONC","LU1829250122.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633416218","title":"港股异动 | 百济神州(06160)绩后高开逾4% 一季度净利同比增长178.02倍 百悦泽全球销售额11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633416218","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633416218?lang=zh_cn&edition=full","pubTime":"2026-05-07 09:25","pubTimestamp":1778117150,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州绩后高开逾4%，截至发稿，涨4.07%，报189.4港元，成交额4130.72万港元。消息面上，5月6日，百济神州公布2026年第一季度业绩，全球总收入达约15.13亿美元，同比增长35%。经调整经营利润约4.14亿美元，同比增长197%；经调整净利润约3.75亿美元，同比增长175%；净利润约2.27亿美元，同比增长178.02倍；自由现金流约1.61亿美元，同比增长14.03倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06160","BK1500","VXUS","LU1719994722.HKD","BK4585","LU1770034418.SGD","688235","BK4526","LU1969619763.USD","BK0239","LU1303224171.USD","BK4139","LU0307460666.USD","LU1251922891.USD","LU2328871848.SGD","BK4588","BK1161","ONC","BK1583","BK1588","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633162625","title":"港股开盘强势 恒指高开1.21% 快手-W(01024)涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633162625","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633162625?lang=zh_cn&edition=full","pubTime":"2026-05-07 09:24","pubTimestamp":1778117045,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美伊将达成结束战争协议，刺激大市气氛向上，隔晚美股强势带动港股情绪，恒指高开1.21%，国企指数高开1.3%，恒生科技指数高开2.41%。期内，经调整净利润3.75亿美元，按年增加175%。东方证券高开1.87%，公司宣布，向卖方收购上海证券合计100%股权。该公司已向上海证交所申请A股5月7日复牌。内地股市假后复市，大市走势向好，沪综指高开高走，收市上升1.2%，沪深两市成交额超过三万亿元水平。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"fbe774582fff1943fbc8392a6b2fba8b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980764","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000333","02833","LU0173614495.USD","LU0287142896.SGD","600938","LU0348783233.USD","IE00BQJZWZ67.USD","LU0972618739.USD","LU0348825331.USD","01024","688235","LU0540923850.HKD","SG9999006597.SGD","513600","BK1608","LU0326950275.SGD","LU0675040207.SGD","LU0634319403.HKD","LU0307460666.USD","LU0862451753.SGD","LU0052750758.USD","LU0588546209.SGD","LU1794554557.SGD","06160","CJEWY","LU2039709279.SGD","SGXZ62798434.SGD","LU1634259557.SGD","LU0405327494.USD","SG9999014674.SGD","LU0051755006.USD","LU1813983027.USD","LU0293314216.USD","IE00B19Z5X02.USD","LU0320764599.SGD","LU2399975544.HKD","LU0561508036.HKD","LU0072462343.USD","LU0640798160.USD","00883","09888","00857","BK1615","LU0593848301.USD","LU1023057109.AUD","LU1719994722.HKD","LU1522347837.USD","603993","BK4585","LU1048588211.SGD","LU1785774172.SGD","HSTECH","LU1831875114.USD","LU0348783662.USD","LU0469268626.HKD","LU0572944931.SGD","BK4588","ONC","SG9999004220.SGD","LU1282651121.HKD","LU2097828714.EUR","LU0348827113.USD","LU1808992512.USD","LU2097828631.EUR","LU2328871848.SGD","LU1770034418.SGD","BABA","LU0862451837.USD","CSUAY","BK1590","LU1115378108.SGD","03993","01378","BIDU","LU0456827905.SGD","LU0211977185.USD","81024","SG9999001093.SGD","SG9999003461.SGD","09961","LU0348767384.USD","LU1497733631.SGD","LU0405327148.USD","LU2097828557.USD","600958","LU1188198961.HKD","BK1528","LU0611395673.USD","BK1591","01929","LU1497733557.USD","LU0417516571.SGD","BK1226","00300","HHImain","SGXZ86797644.SGD","LU0359201612.USD","LU0359202008.SGD","601857","LU2293587155.HKD","LU2097828474.EUR","LU0890818403.SGD","BK1147","TCOM","LU1969619763.USD","LU0314109678.HKD","LU0417516738.SGD","LU0708995583.HKD","LU1224444064.USD","LU0348784397.USD","BK1610","601088","03958","BK1564","LU1328277881.USD","09988","LU0210526637.USD","LU0348735423.USD","LU0441854154.USD","LU0181495838.USD","LU0140636845.USD","01088","LU0417516902.SGD","BK1095","LU0348766576.USD","LU0359201885.HKD","LU1961090484.USD","MCHmain","IE00BWDBJ730.SGD","LU1634259391.SGD","BK1575","XYIGY","LU1303224171.USD","LU0463099449.HKD","LU0348805143.USD","LU1497734951.SGD","LU1282651048.USD","LU0327786744.USD","LU0244354667.USD","LU2097828805.USD","BK1521","HSI","00868","LU1251922891.USD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633166139","title":"智通港股早知道 | 碳酸锂现货价格大幅上行 百济神州(06160)一季度净利润同比增长178.02倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2633166139","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633166139?lang=zh_cn&edition=full","pubTime":"2026-05-07 07:09","pubTimestamp":1778108970,"startTime":"0","endTime":"0","summary":"前十款智能手机合计贡献了全球 25% 的出货量，创下历年第一季度最高集中度。百济神州：一季度净利润同比增长178.02倍至2.27亿美元智通财经APP讯，百济神州公布2026年第一季度业绩，全球总收入达约15.13亿美元，同比增长35%。经调整经营利润约4.14亿美元，同比增长197%；经调整净利润约3.75亿美元，同比增长175%；净利润约2.27亿美元，同比增长178.02倍；自由现金流约1.61亿美元，同比增长14.03倍。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06160","688235","VXUS","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159265378","title":"异动解读 | 一季度业绩扭亏为盈并上调全年预期，百济神州盘中大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159265378","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159265378?lang=zh_cn&edition=full","pubTime":"2026-05-06 23:17","pubTimestamp":1778080652,"startTime":"0","endTime":"0","summary":"百济神州今日盘中大涨5.19%，引起了市场的广泛关注。业绩增长主要得益于核心产品百悦泽全球销售额的强劲增长，该产品第一季度销售额达75.98亿元，同比增长33.5%，其中欧洲市场增速尤为亮眼，达51.4%。与此同时，公司基于核心产品在美国市场的领先地位及在欧洲等重要市场的持续扩张，上调了2026年全年业绩指引，预计全年营业收入区间上限从450亿元提升至452亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633139629","title":"核心产品放量！百济神州一季度营收达105亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633139629","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633139629?lang=zh_cn&edition=full","pubTime":"2026-05-06 21:26","pubTimestamp":1778073960,"startTime":"0","endTime":"0","summary":"5月6日，百济神州（纳斯达克代码：ONC；香港联交所代码：06160；上交所代码：688235.SH）发布2026年第一季度业绩报告。报告期内，公司营业总收入为105.44亿元，同比增长31.0%。产品收入占总营收98%，达103.21亿元，同比增长29.3%，主要得益于百悦泽?（泽布替尼），以及安进公司授权产品和百泽安?（替雷利珠单抗）的销售增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605063728968110.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605063728968110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06160","688235","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633180313","title":"百济神州(688235.SH)：2026年第一季度归母净利润16.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633180313","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633180313?lang=zh_cn&edition=full","pubTime":"2026-05-06 19:37","pubTimestamp":1778067472,"startTime":"0","endTime":"0","summary":"百济神州(688235.SH)发布公告，2026年第一季度公司产品收入为103.21亿元，较上年同比上升29.3%;2026年第一季度公司营业总收入为105.44亿元，较上年同比上升31.0%;2026年第一季度归属于母公司所有者的净利润为16.08亿元。报告期末，公司总资产为590.69亿元，较期初增加3.1%;归属于母公司的所有者权益为330.31亿元，较期初增加7.8%。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/astock/4.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/4.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438702.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["ONC","688235","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117917036","title":"百济神州Q1净利润16.08亿元，同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1117917036","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117917036?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:34","pubTimestamp":1778063668,"startTime":"0","endTime":"0","summary":"5月6日，$百济神州(ONC)$盘前涨近5%！该公司一季度营收为105.44亿元，同比增长31%；净利润为16.08亿元，上年同期亏损9450.3万元，同比扭亏为盈。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ca0e3dea87604e6a95a3bf5695c5bcab","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"百济神州Q1净利润16.08亿元，同比扭亏为盈","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","BK1588","688235","BK1161","BK4526","BK4588","LU0307460666.USD","BK0239","BK4585","LU1251922891.USD","LU1303224171.USD","BK1583","LU1770034418.SGD","LU2328871848.SGD","LU1719994722.HKD","ONC","06160","LU1969619763.USD","LU0588546209.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632618011","title":"百济神州首次全年盈利背后：累计亏损超600亿元，大单品依赖与地缘政治隐忧｜财报异动透视镜","url":"https://stock-news.laohu8.com/highlight/detail?id=2632618011","media":"华夏时报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632618011?lang=zh_cn&edition=full","pubTime":"2026-05-01 16:32","pubTimestamp":1777624341,"startTime":"0","endTime":"0","summary":"这家中国抗癌药明星企业交出了史上首份盈利年报，但高达612亿元的累计未弥补亏损、对单一产品的深度依赖，以及愈演愈烈的中美药品定价博弈，令其“全球肿瘤创新公司”的故事蒙上阴影。对百济神州而言，2025年本应是举杯相庆的一年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605013727283548.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605013727283548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","688235","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109645758","title":"财报前瞻｜百济神州本季度营收预计增19.61%，机构观点偏向谨慎乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1109645758","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109645758?lang=zh_cn&edition=full","pubTime":"2026-04-29 09:07","pubTimestamp":1777424834,"startTime":"0","endTime":"0","summary":"百济神州将于2026年05月06日发布新一季度财报，市场关注度聚焦收入增速与利润改善的持续性，以及核心产品放量节奏与费用率控制的平衡。综合一致性预期，本季度百济神州营收预计为13.36亿美元，同比增长19.61%；调整后每股收益预计为0.87美元，同比增长221.34%；息税前利润预计为1.08亿美元，同比增长243.42%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜百济神州本季度营收预计增19.61%，机构观点偏向谨慎乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":-0.0568},{"period":"1month","weight":-0.095},{"period":"3month","weight":-0.1741},{"period":"6month","weight":-0.1716},{"period":"1year","weight":0.2833},{"period":"ytd","weight":-0.0353}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"　　百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是抗肿瘤类药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.083709},{"month":2,"riseRate":0.6,"avgChangeRate":0.027535},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.02929},{"month":4,"riseRate":0.363636,"avgChangeRate":0.018832},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.018029},{"month":6,"riseRate":0.5,"avgChangeRate":0.012468},{"month":7,"riseRate":0.8,"avgChangeRate":0.147208},{"month":8,"riseRate":0.6,"avgChangeRate":0.034201},{"month":9,"riseRate":0.6,"avgChangeRate":0.069537},{"month":10,"riseRate":0.5,"avgChangeRate":-0.004517},{"month":11,"riseRate":0.6,"avgChangeRate":0.063715},{"month":12,"riseRate":0.3,"avgChangeRate":-0.043663}],"exchange":"NASDAQ","name":"百济神州","nameEN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(ONC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,ONC,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(ONC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}